CAL
QLTY icon

Capital Analysts LLC’s GMO US Quality ETF QLTY Stock Holding History

Capital Analysts LLC’s Portfolio QLTY Stock Details QLTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-895
Closed -$34K – 1580
2025
Q4 		$34K Buy
+895
New +$33.7K ﹤0.01% 1003

Other funds holding QLTY

AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $1.07B AUM 26.49% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

Capital Analysts LLC's QLTY Position: Q1 2026 in Review

Capital Analysts LLC sold out of GMO US Quality ETF (QLTY) in Q1 2026, closing a stake of 895 shares — an estimated $34K sold.

Capital Analysts LLC first reported a position in QLTY in Q4 2025 and held it in 1 quarter. The position peaked at $34K in Q4 2025. 151 funds tracked by Wall St. Rank hold QLTY as of Q1 2026.

  • Capital Analysts LLC reported no remaining GMO US Quality ETF position as of Q1 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 895 GMO US Quality ETF shares in Q1 2026, an estimated $34K.
  • Capital Analysts LLC first reported a position in GMO US Quality ETF in Q4 2025 and held it in 1 quarter.
  • Capital Analysts LLC's GMO US Quality ETF position peaked at $34K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.